INCLINED SEDIMENTATION FOR SELECTIVE RETENTION OF VIABLE HYBRIDOMAS IN A CONTINUOUS SUSPENSION BIOREACTOR

被引:73
作者
BATT, BC [1 ]
DAVIS, RH [1 ]
KOMPALA, DS [1 ]
机构
[1] UNIV COLORADO,DEPT CHEM ENGN,BOULDER,CO 80309
关键词
D O I
10.1021/bp00006a600
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The continuous separation of nonviable hybridoma cells from viable hybridoma cells by using a narrow rectangular channel that is inclined from the vertical has been investigated experimentally. The effectiveness of the settler in selectively retaining viable hybridomas in te bioreactor while permitting the removal of nonviable hybridomas has been shown to depend on the flow rate through the settler. Intermediate flow rates through the settler have been found to provide the highest removal of nonviable hybridomas relative to viable hybridoma retention. At high dilution rates through the chemostat, over 95% of the viable cells could be partitioned to the bottom of the settler while over 50% of the nonviable cells are removed through the top of the settler. This successful separation is due to the significantly larger size of the viable hybridomas than the nonviable ones. A continuous perfusion experiment was performed in which an external inclined settler was used to retain virtually all of the viable hybridomas in the culture, while selectively removing from the culture approximately 20% of the nonviable cells that entered the settler. A stable viable cell concentration of 1.0 x 10(7) cells/mL was achieved, as was an antibody productivity of over 50-mu-g (mL.day). These represent 3- and 6-fold increases, respectively, over the values obtained form a chemostat culture without cell retention.
引用
收藏
页码:458 / 464
页数:7
相关论文
共 30 条
  • [1] Fazekas de St. Groth S., Automated Production of Monoclonal Antibodies in a Cytostat, J. Immunol. Methods, 57, pp. 21-36, (1983)
  • [2] Boraston R., Thompson P., Garland S., Birch J., Growth and Oxygen Requirements of Antibody Producing Mouse Hybridoma Cells in Suspension Culture, Dev. Biol. Stand., 55, pp. 103-111, (1984)
  • [3] Reuveny S., Velez D., Riske F., Macmillan J., Miller J., Production of Monoclonal Antibodies in Culture, Dev. Biol. Stand., 60, pp. 185-197, (1985)
  • [4] Birch J., Thompson P., Lambert K., Boraston R., The Large Scale Cultivation of Hybridoma Cells Producing Monoclonal Antibodies, Large‐Scale Mammalian Cell Culture, pp. 1-16, (1985)
  • [5] Luan Y., Mutharasan R., Magee W., Strategies to Extend Longevity of Hybridomas in Culture and Promote Yield of Monoclonal Antibodies, Biotechnol. Lett., 9, 10, pp. 691-696, (1987)
  • [6] Renard J.M., Spagnoli R., Mazier C., Salles M.F., Mandine E., Evidence that Monoclonal Antibody Production Kinetics is Related to the Integral of the Viable Cells Curve in Batch Systems, Biotechnol. Lett., 10, 2, pp. 91-96, (1988)
  • [7] Reddy S., Miller W.M., (1989)
  • [8] van Wezel A., van der Veldon-de Groot C., de Haan H., van den Heuvel N., Schasfoort R., Large Scale Animal Cell Cultivation for Production of Cellular Biologicals, Dev. Biol. Stand., 60, pp. 229-236, (1985)
  • [9] Reuveny S., Velez D., Macmillan J., Miller L., Comparison of Cell Propagation Methods for their Effect on Monoclonal Antibody Yield in Fermentors, J. Immunol. Methods, 86, pp. 61-69, (1986)
  • [10] Tolbert W., Lewis C., White P., Feder J., Perfusion Culture Systems for Production of Mammalian Cell Biomolecules, Large‐Scale Mammalian Cell Culture, pp. 1-98